BIOLIT ApS: Financial statements 2025
CVR: 10068460
BIOLIT ApS (CVR 10068460) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 125,902 and a net result of DKK -20,616,619 compared with DKK 13,041,006 the year before. That is an increase of 109.1% compared with the year before. Equity amounted to DKK 10,762,624. The solvency ratio was 41.5%.
- Gross Profit
- 125,902 kr.
- Profit/Loss
- -20,616,619 kr.
- Equity
- 10,762,624 kr.
- Total Assets
- 25,927,187 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 126 t. | -20.6 mio. | 10.8 mio. | 0 |
| 2024 | - | 60 t. | 13 mio. | 31.4 mio. | 0 |
| 2023 | - | 974 t. | 4.8 mio. | 18.3 mio. | 0 |
| 2022 | - | 2.4 mio. | 3.2 mio. | 13.6 mio. | 0 |
| 2021 | - | 1.8 mio. | 1.6 mio. | 10.4 mio. | 0 |
Find more companies like BIOLIT ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout BIOLIT ApS
BIOLIT ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Flemming Velin. The company is owned by SCANVET ANIMAL HEALTH A/S. The company has 3 employees. In 2025, the company reported a gross profit of DKK 125,902 and a net result of DKK -20,616,619 compared with DKK 13,041,006 the year before. Equity amounted to DKK 10,762,624.
